Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study

Kwaku Marfo; Samuel Aitken; Enver Akalin

Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study

Kwaku Marfo, Samuel Aitken, Enver Akalin

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	484-488
Number of pages	5
Journal	P and T
Volume	38
Issue number	8
State	Published - Aug 2013

ASJC Scopus subject areas

Pharmacology (medical)

Cite this

@article{7bb34d8bdc1b49d6897c2c2e63f92ea1,

title = "Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study",

author = "Kwaku Marfo and Samuel Aitken and Enver Akalin",

year = "2013",

month = aug,

language = "English (US)",

volume = "38",

pages = "484--488",

journal = "P and T",

issn = "1052-1372",

publisher = "MediMedia USA Inc.",

number = "8",

}

TY - JOUR

T1 - Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients

T2 - A retrospective cohort study

AU - Marfo, Kwaku

AU - Aitken, Samuel

AU - Akalin, Enver

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84882596047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882596047&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84882596047

SN - 1052-1372

VL - 38

SP - 484

EP - 488

JO - P and T

JF - P and T

IS - 8

ER -

Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study

ASJC Scopus subject areas

Other files and links

Cite this